Maven Income
and Growth VCT 5 PLC
Interim Results
for the Six Months Ended 31 May 2024 (Unaudited)
The Directors announce the Interim Review and
the unaudited Financial Statements for the six months ended 31 May
2024.
Highlights
• NAV total
return at 31 May 2024 of 84.09p per share
• NAV at 31 May
2024 of 32.09p per share
• Interim
dividend of 1.00p per share
• Offer for
Subscription closed, raising £6.8 million
• Four new
private companies added to the portfolio
• Exit achieved
from GradTouch, generating a total return of 1.7x cost
• Post period
end, final exit achieved from Quorum Cyber, generating a total
return of 8.2x cost
Interim
Review
Overview
In the six months to 31 May 2024, your Company
has made further positive progress and it is pleasing to report a
modest increase in NAV total return. Since the year end, your
Company has closed its most recent Offer for Subscription,
completed four new private company investments and achieved three
profitable private company realisations, including the final exit
from Quorum Cyber, which generated a total return of 8.2x cost over
a holding period of less than four years. In general, the portfolio
of investee companies continues to deliver a resilient performance
and remains well placed to achieve further growth. In recognition
of the exit activity and the commitment to make regular tax free
distributions, an interim dividend of 1.00p per share has been
declared for payment in September 2024.
Following a prolonged period of macroeconomic
uncertainty, it is encouraging to note that market conditions are
improving. With inflation significantly reduced, energy prices in
decline and interest rates predicted to fall later in the year, the
outlook is more stable than it has been for several years. Whilst
it may take time for all of these improvements to filter through
the economy, the Manager is cautiously optimistic in the outlook
for the remainder of the financial year and believes that economic
growth will continue to strengthen in 2025.
Your Company continues to make further
progress in line with its long term growth strategy, which is
focused on constructing a large and diverse portfolio of innovative
companies that will scale and ultimately become attractive to a
wide range of acquirers. During the reporting period, there was a
good level of investment with the addition of four new private
companies to the portfolio, alongside the provision of follow-on
funding to support the further development of seven existing
portfolio holdings, resulting in the deployment of £1.8 million.
The investment strategy continues to focus on identifying
entrepreneurial companies that operate in disruptive or high growth
markets, where there is an opportunity to achieve scale over the
medium term. Maven retains a strong preference for investing in
companies that operate in dynamic sectors such as cyber security,
software, niche manufacturing, data analytics, healthtech and
training, where growth is less sensitive to consumer or
discretionary spending and the revenue model tends to be recurring
in nature, which provides good visibility on the growth trajectory
of each portfolio company. To ensure the business plan can be
delivered, Maven also spends time assessing the calibre of
management and their track record, recognising that ambitious and
cohesive teams are crucial to the success of early stage
businesses.
In April 2024, your Company closed its most
recent top-up Offer having raised a total of £6.8 million for the
2023/24 and 2024/25 tax years. These funds will enable your Company
to progress its investment strategy which, over the past four
years, has provided growth capital to more than 40 private
companies, many of which are delivering strong growth and achieving
a leading position in their respective markets. As the portfolio
develops, it is becoming evident that there are a number of high
performing companies which have the capability of achieving
superior returns at exit.
Over recent months, there has been an increase
in the level of acquisition interest across the portfolio with
approaches to acquire or invest in several investee companies,
particularly from US investors, who are interested in the UK
technology sector. This is demonstrated by the recent successful
exit from cyber security specialist Quorum Cyber, which completed in early
June. Your Company first invested in Quorum Cyber in 2020, backing
an experienced team that had quickly established a leading position
in a high growth market. Following a period of rapid expansion, the
investment was partially realised through a sale to UK private
equity house Livingbridge in December 2021, generating an initial
return of 6.5x cost over an 18 month holding period. This
transaction provided Quorum Cyber with additional capital to
support the next phase of its strategic development and, in
recognition of its continuing potential, the Maven VCTs retained a
minority equity interest in the business in order to participate in
future growth. It is pleasing to report that in June this year, a
final exit from this investment was achieved through a sale of the
business to US private equity firm, Charlesbank Capital Partners,
taking the total proceeds to 8.2x cost.
Whilst achieving profitable exits in pursuit
of Shareholder returns remains a key priority, this has to be
balanced against selling a business too early before its value has
been fully optimised. In cases like Quorum Cyber, where a business
is performing strongly and has the potential to become a large and
valuable asset, the Manager will seek, where possible, to retain an
economic interest when structuring an exit. This approach will
allow your Company to generate an initial cash return from a
secondary transaction or partial sale, to help support the dividend
programme, whilst retaining an ongoing equity interest in the
business, which offers the potential for a further return in the
future.
Dividend
Policy
The Board and the Manager recognise the
importance of tax free distributions to Shareholders and will seek,
as a guide, to pay an annual dividend that represents 5% of the NAV
per share at the immediately preceding year end.
Decisions on distributions take into
consideration a number of factors, including the realisation of
capital gains, the adequacy of distributable reserves, the
availability of surplus revenue and the VCT qualifying level, all
of which are kept under close and regular review. As the portfolio
continues to expand and a greater proportion of holdings are
invested in younger companies with growth potential, the timing of
distributions will be more closely linked to realisation activity,
whilst also reflecting the Company's requirement to maintain its
VCT qualifying level.
Interim
Dividend
In respect of the year ending 30 November
2024, an interim dividend of 1.00p per share will be paid on 6
September 2024 to Shareholders who are on the register at 9 August
2024. Since the Company's launch, and after receipt of this interim
dividend, a total of 53.00p per share will have been paid in tax
free Shareholder distributions. It should be noted that payment of
a dividend reduces the NAV of the Company by the total amount of
the distribution.
Dividend
Investment Scheme (DIS)
Your Company operates a DIS, through which
Shareholders can, at any time, elect to have their dividend
payments utilised to subscribe for new Ordinary Shares issued by
the Company under the standing authority requested from
Shareholders at Annual General Meetings. Shares issued under the
DIS should qualify for VCT tax relief applicable for the tax year
in which they are allotted, subject to an individual Shareholder's
particular circumstances.
Shareholders can elect to participate in the
DIS in respect of future dividends by completing a DIS mandate form
and returning it to the Registrar (The City Partnership). In order
for the DIS to apply to the 2024 interim dividend, the mandate form
must be received before 23 August 2024, this being the relevant
dividend election date. The mandate form, terms & conditions
and full details of the scheme (including tax considerations) are
available from the Company's webpages at: mavencp.com/migvct5. Election to
participate in the DIS can also be made through the Registrar's
online investor hub at: maven-cp.cityhub.uk.com/login.
If a Shareholder is in any doubt about the
merits of participating in the DIS, or their own tax status, they
should seek advice from a suitably qualified adviser.
Offer for
Subscription
The most recent Offer for Subscription closed
to new applications on 26 April 2024, with your Company raising a
total of £6.8 million for the 2023/24 and 2024/25 tax years. All
new shares in relation to this Offer have now been allotted with
four allotments for the 2023/24 tax and one allotment for the
2024/25 tax year.
This additional liquidity will facilitate the
further expansion and development of the portfolio in line with the
investment strategy. The funds raised will also allow your Company
to maintain its share buy-back policy, whilst also spreading costs
over a wider asset base, with the objective of maintaining a
competitive ongoing charges ratio for the benefit of all
Shareholders.
As announced on 18 June 2024, the Directors
have elected to launch a new Offer for Subscription, which will run
alongside Offers by the other Maven managed VCTs. Full details will
be included in the Prospectus, which is expected to be published in
Autumn 2024.
Portfolio
Developments
It is encouraging to report on the progress
that has been achieved across the private equity portfolio, where
most companies have continued to meet operational and financial
targets as part of their business plans. Notably, many of the
earlier stage growth companies are now achieving scale and
establishing strong positions in their respective markets, and in
recognition of the progress achieved the valuations of certain
holdings have been uplifted.
Carbon reduction software specialist
Manufacture 2030 has
delivered strong revenue growth over the past year, with annual
recurring revenue (ARR) increasing by over 75%. The business
provides a disruptive software solution that helps multinationals
achieve Scope 3 carbon reduction targets by measuring, managing and
reducing carbon emissions across their supply chain. The business
is establishing a strong position in a high growth market, where
its proposition is aligned with various carbon reduction
initiatives, including the United Nations Sustainable Development
Goals. Manufacture 2030 partners with a wide range of blue chip
clients including Asda, Co-op, GSK, Toyota and Unilever, and has
received a number of awards as a technology pioneer within this
evolving market. The near term objective is to expand its presence
in North America, which is viewed as a key market.
Specialist electronics manufacturer
CB Technology delivered a
positive performance in its latest financial year and continues to
build a strong forward orderbook, which provides good visibility
for the year ahead. CB Technology has also secured a number of new
clients as part of a successful diversification strategy, with the
objective of reducing the reliance on oil & gas
customers.
Cyber security specialist CYSIAM has made further commercial
progress with revenues increasing by more than 200% since your
Company first invested. The business is building a strong
reputation as a leading provider of Managed Detection and Response
(MDR) security services for protection against, detection of, and
response to cyber attacks. CYSIAM is a recognised expert in its
field and, as an accredited member of the National Cyber Security
Centre's Cyber Incident Response scheme, it can provide direct
support to a range of organisations when they become victims of
cyber attacks. CYSIAM operates in a dynamic, high growth market and
the near term strategic objective remains to further pivot the
business towards a Software as a Service (SaaS) model, which will
result in an increased level of recurring revenue.
In 2021, your Company invested in Guru Systems a supplier of hardware,
software and data analytics designed to improve the performance and
cost effectiveness of heat networks. Since investment, the business
has gained commercial traction in an emerging sector that has
positive ESG credentials. Heat networks are an important part of
the government's decarbonisation strategy and are increasingly
required to be included as part of the design of any new
residential and commercial property developments. Given the strong
growth potential of this market, Guru is well placed to achieve
scale over the medium term.
During the period under review, digital
archiving specialist MirrorWeb has continued to deliver
impressive revenue growth and add new clients. Following the
relocation of the CEO to the US to lead the international expansion
strategy, the business has continued to scale rapidly, particularly
in the financial services sector, where regulatory changes now
require all digital communications to be archived. MirrorWeb has
also focused on developing a new platform with enhancements and
additional product functionality, which provides good upselling
potential within the existing client base.
Automotive ecommerce software specialist
Rockar continues to grow
market share and is now a leading provider of a white label
disruptive solution for buying and selling new and used cars
online. The business has developed good relationships with various
high profile automotive manufacturers such as BMW, Jaguar Land
Rover, Toyota Motor Group and Volvo UK, with development work
ongoing with several others. Rockar's new operating platform,
Evolution, is gaining
traction amongst clients, with a number already using or committed
to migrating across to the new operating system. The business
continues to deliver strong revenue growth and remains focused on
building relationships with global automotive manufacturers that
will enable the company to achieve further scale.
Digital payments software provider
QikServe has continued to
make encouraging commercial progress and is capitalising on the
shift within the hospitality sector towards mobile ordering and
pay-at-table technology.
The business continues to expand its market presence in targeted
sectors, which include restaurants, international coffee chains and
transportation hubs. QikServe has a growing estate with more than
8,000 sites in over 40 countries and a healthy pipeline of near
term opportunities, particularly in the US.
Contract software specialist Summize continues to make positive
commercial progress, with ARR growing by almost 200% since the
investment first completed in October 2022. Summize has developed
an AI-powered digital contracting software solution that simplifies
and streamlines the process for writing and renewing contracts,
helping to drive operational efficiencies for customers. Since
inception in 2018, Summize has secured numerous industry awards for
its innovation and entrepreneurialism. Having established a strong
foothold in the UK, the next phase of growth for the business is to
expand into the US, where it has the potential to exploit a
significant market opportunity.
As may be expected with a large portfolio,
there are a small number of investee companies that have not
achieved commercial targets and are trading behind plan. Protective
provisions have, therefore, been taken against the cost of certain
holdings.
The performance of fintech specialist
Delio has been impacted by
slower than expected sales cycles and although corrective measures
have been taken, the business continues to trade behind plan. It is
disappointing to report that the small investment in marketing
technology business Drovo
has been written down in full.
Quoted
Holdings
Following a challenging year for markets in
2023, there are signs that AIM has stabilised, with the FTSE AIM
All-Share Index increasing by 12.9% over the period under review,
and your Company's AIM quoted portfolio rising by 7.7%. The Manager
continues to review a wider range of AIM investment proposals but
will maintain a highly selective approach to supporting any new
investment opportunities.
Concurrent
Technologies, the designer and manufacturer of
high performance embedded computing solutions, delivered record
revenues and profitability in the full year to 31 December 2023.
Annual revenue grew by 73% to £31.7 million, driven by robust
demand from defence customers, which account for 85% of total
revenue, with profit before tax (PBT) increasing to £3.7 million.
The cash position at the end of the year was £11.1 million, of
which £5.6 million was generated from operating activities.
Concurrent has maintained this positive momentum into the new
financial year with trading in the first four months of the year in
line in market expectations.
Predictive health technology specialist
GENinCode, which focuses on
genetic risk assessments of cardiovascular disease and ovarian
cancer, published encouraging results for the full year to 31
December 2023. During the year, revenue increased by 51% to £2.2
million, driven by increased usage of its tests in the UK and
Europe. The business also commenced commercial programmes in the US
for its cardiovascular disease genetic risk assessments and filed
for Food and Drug Administration (FDA) approval of the CARDIO inCode device, a polygenic risk
assessment of coronary heart disease. In January 2024, your Company
participated in a small follow-on fundraise to support the business
through the approval timeline to the point of the first commercial
sale of LIPID inCode, a
genetic diagnosis and risk assessment of familial
hypercholesterolemia.
In the first half of the year to 31 December
2023, customer engagement software specialist Netcall reported revenue growth of 8%
to £18.9 million, driven by growth in cloud services, with
recurring revenue increasing to 75% of total revenue. PBT was 61%
higher at £3.8 million, with the cash position at the period end
increasing to £28.6 million. The business has seen ongoing positive
momentum into the second half of the year, as it continues to
benefit from favourable market conditions, including the rapid
acceleration of cloud and AI technologies.
Security and surveillance specialist
Synectics reported good
growth in the year to 30 November 2023 driven by strong demand from
the oil & gas sector. Revenue rose by 26% to £49.1 million,
with underlying PBT up 190% to £2.9 million. There was strong cash
generation from operating activities, and, at the year end, the
cash position was £4.6 million, with the final dividend increased
by 50% to 3p per share. This positive momentum had continued into
the new financial year, and trading remains comfortably in line
with market expectations.
Water
Intelligence, a provider of minimally invasive
leak detection and remediation solutions, released an encouraging
trading update for the year to 31 December 2023. During the period,
revenue increased by 7% to $76 million, with adjusted PBT
increasing by 12% to $8.7 million. This was followed by a similarly
positive quarterly trading update for the period to 31 March 2024,
which stated that revenue was 6% ahead at $20.5 million, with
adjusted PBT growing 8% to $2.5 million. Post the quarter end, the
company announced another franchise reacquisition and a new
franchise arrangement, both of which are expected to provide
positive momentum going forward.
Treasury
Management
Your Company maintains a proactive approach to
treasury management, where the objective remains to optimise the
income generated from cash held prior to investment in VCT
qualifying companies, whilst meeting the requirements of the Nature
of Income condition. This is a mandatory part of the VCT
legislation, which stipulates that not less than 70% of a VCT's
income must be derived from shares or securities. During 2023, the
rise in interest rates required the Board and the Manager to revise
its approach and, following a whole of market review, the
composition of the treasury management portfolio was expanded to
include holdings in leading money market funds and open-ended
investment companies (OEICs), alongside carefully selected London
Stock Exchange listed investment trusts. This approach enables your
Company to maintain compliance with the Nature of Income condition,
whilst also generating a healthy new stream of income from the
portfolio of treasury management holdings and cash.
In line with the liquidity requirements of
your Company, there were several new investments and realisations
within this portfolio, details of which can be found in the Interim
Report.
New
Investments
During the reporting period, four new private
companies were added to the portfolio:
• Alderley Lighthouse Labs is a provider
of clinical diagnostic testing services, specialising in the
analysis of human samples such as blood, urine and cells, with the
objective of improving healthcare outcomes. The business was
initially established as a COVID-19 testing facility, as part of
the Government supported "Test and Trace" programme. As pandemic
related testing subsided, the business evolved into a
laboratory-based facility providing blood science and molecular
diagnostics to a wide range of clients. The healthcare diagnostics
and testing market continues to experience high growth, and
Alderley is well placed to leverage its existing position, with
scope to achieve considerable scale. The funding from the Maven
VCTs provides capital that will enable the business to invest in
product development, expand its current suite of services and grow
monthly revenues.
• McKenzie Intelligence Services (MIS) is
an insurtech business that provides insurers with geospatial data
and analysis to accelerate responses to catastrophic events,
helping to drive disaster relief and economic recovery. Its
proprietary data-led intelligence platform, Global Events Observer, uses real time
information, machine learning and expert analysis to provide
detailed and actionable intelligence to help decision makers manage
risk, escalate relief and promote economic recovery in scenarios of
extreme weather, natural disasters and geopolitical conflict. Since
2017, MIS has been Lloyds of London's catastrophic claims partner
and has provided data and assistance following several high profile
incidents, including the 2023 wildfires in Hawaii. The funding from
the Maven VCTs is being used to further develop the technology
platform and to launch new products that offer unique insight into
future potential risks.
• Metrion Biosciences is a specialist
contract research organisation that provides drug discovery
services to pharma and biotech customers. Its highly specialised
service is required in the development of drugs that intentionally
or unintentionally act on an important group of protein structures
within the body known as ion
channels, which are one of the fastest growing areas of
innovation in drug discovery. Metrion is aiming to become the
outsourcing partner of choice for ion channel services in the
global pharma and biotech industry. The funding from the Maven VCTs
is being used to invest in new equipment and to create additional
laboratory space, which will enable Metrion to achieve greater
scale in this growing market.
• Zing is a specialist services provider
operating in the cloud-communications sector. It is a leading
partner of global cloud communication platform business, Twilio,
providing consultancy and managed services. Zing was a spin out
from CRM provider ProspectSoft, a previous Maven portfolio company,
which was successfully exited in 2022. The funding from the Maven
VCTs will enable the business to capitalise on the growth
opportunities in the Communications Platform as a Service (CPaaS)
market. Since becoming an independent business, Zing has made
encouraging commercial progress and strengthened its relationship
with Twilio. The next stage of development is focused on expanding
into the US, developing a new AI proposition, and enhancing the
management team through new strategic hires.
The following investments were completed
during the reporting period:
Investments
|
Date
|
Sector
|
£'000
|
|
New
unlisted
|
|
|
|
|
Alderley Lighthouse Labs Limited1
|
April & May 2024
|
Pharmaceuticals,
biotechnology &
healthcare
|
248
|
|
McKenzie Intelligence Services Limited
|
December 2023
|
Business services
|
159
|
|
Metrion Biosciences Limited
|
December 2023
|
Pharmaceuticals,
biotechnology &
healthcare
|
597
|
|
Zing TopCo Limited (trading as Zing)1
|
April & May 2024
|
Business services
|
185
|
|
Total new
unlisted
|
|
|
1,189
|
|
Follow-on
unlisted
|
|
|
|
|
Hublsoft Group Limited
|
April 2024
|
Software &
technology
|
56
|
|
Liftango Group Limited
|
March 2024
|
Software &
technology
|
48
|
|
Relative Insight Limited
|
February 2024
|
Software &
technology
|
99
|
|
Snappy Shopper Limited
|
April 2024
|
Software &
technology
|
9
|
|
Whiterock Group Limited
|
December 2024
|
Software &
technology
|
199
|
|
Zinc Digital Business Solutions Limited
|
May 2024
|
Software &
technology
|
50
|
|
Total follow-on
unlisted
|
|
|
461
|
|
|
|
|
|
|
Total
unlisted
|
|
|
1,650
|
|
Follow-on AIM
quoted
|
|
|
|
|
GENinCode PLC
|
January 2024
|
Pharmaceuticals,
biotechnology &
healthcare
|
160
|
|
Total follow-on AIM
quoted
|
|
|
160
|
|
Open-ended investment
companies2
|
|
|
|
Royal London Short Term Money Market Fund (Class Y
Income)
|
April 2024
|
Money market fund
|
1,000
|
Total open-ended
investment companies
|
|
|
1,000
|
Money market
funds2
|
|
|
|
Aberdeen Standard Liquidity Fund (Lux) - Sterling Fund
(Class K3)
|
March 2024
|
Money market fund
|
500
|
Fidelity Institutional Liquidity Sterling Fund (Class
F)
|
March 2024
|
Money market fund
|
1,000
|
HSBC Sterling Liquidity Fund (Class A)
|
May 2024
|
Money market fund
|
1,000
|
Total money market
funds
|
|
|
2,500
|
Private equity
investment trusts2
|
|
|
|
Caledonia Investments PLC
|
May 2024
|
Investment trust
|
111
|
CT Private Equity Trust PLC
|
May 2024
|
Investment trust
|
300
|
ICG Enterprise Trust PLC
|
May 2024
|
Investment trust
|
51
|
Pantheon International PLC
|
May 2024
|
Investment trust
|
129
|
Total private equity
investment trusts
|
|
|
591
|
Infrastructure
investment trusts2
|
|
|
|
BBGI Global Infrastructure SA
|
May 2024
|
Investment trust
|
52
|
Pantheon Infrastructure PLC
|
May 2024
|
Investment trust
|
13
|
Total infrastructure
investment trusts
|
|
|
65
|
|
|
|
|
Total
investments
|
|
|
5,966
|
|
|
|
|
| |
1 Follow-on investment completed in two tranches.
2 Investments completed as part of the treasury management
strategy.
At the period end, the portfolio comprised of
137 unlisted and quoted investments, at a total cost of £62.2
million.
Realisations
In December 2023, the exit from Glacier Energy Services completed,
through a sale to a private equity buyer, which generated a total
return of 1.05x cost over the life of the investment. Glacier was
one of the more mature holdings in the portfolio and the exit helps
further reduce your Company's exposure to the energy services
sector.
In May 2024, the exit from graduate recruitment
specialist GradTouch
completed. Your Company first invested in GradTouch in November
2019, backing a team with a strategic plan to build a market
leading position in the graduate recruitment market. Throughout the
period of ownership, the company achieved steady organic growth
alongside completing a series of self funded, complementary
acquisitions, which helped transform the business. During the
period under review, an offer to acquire the business was received
from UK private equity house Pelican Capital, which generated a
total return of 1.7x cost, inclusive of a small deferred
consideration.
The table below gives details of the realisations
completed during the reporting period:
Realisations
|
Year first
invested
|
Complete/
partial exit
|
Cost of shares disposed
of
£'000
|
Value at 30 November
2023
£'000
|
Sales
proceeds
£'000
|
Realised
gain/(loss)
£'000
|
Gain/(loss) over 30 November
2023 value
£'000
|
Unlisted
|
|
|
|
|
|
|
|
Glacier Energy Services Holdings Limited
|
2011
|
Complete
|
643
|
509
|
486
|
(157)
|
(23)
|
GradTouch Limited
|
2019
|
Complete
|
566
|
955
|
973
|
407
|
18
|
Others
|
|
|
-
|
-
|
6
|
6
|
6
|
Total
unlisted
|
|
|
1,209
|
1,464
|
1,465
|
256
|
1
|
AIM quoted
|
|
|
|
|
|
|
|
Oncimmune Holdings PLC
|
2021
|
Complete
|
249
|
35
|
33
|
(216)
|
(2)
|
SulNOx PLC
|
2021
|
Partial
|
130
|
113
|
153
|
23
|
40
|
Velocys PLC
|
2021
|
Complete
|
148
|
4
|
5
|
(143)
|
1
|
Verici Dx PLC
|
2020
|
Partial
|
7
|
3
|
3
|
(4)
|
-
|
Vertu Motors PLC
|
2007
|
Complete
|
50
|
71
|
59
|
9
|
(12)
|
Total AIM
quoted
|
|
|
584
|
226
|
253
|
(331)
|
27
|
Money market
funds1
|
|
|
|
|
|
|
|
Aberdeen Standard Liquidity Fund (Lux) - Sterling Fund
(Class K3)
|
2023
|
Partial
|
1,000
|
1,000
|
1,000
|
-
|
-
|
Goldman Sachs Sterling Government Liquid Reserves
Ireland (Institutional)
|
2023
|
Complete
|
1,000
|
1,000
|
1,000
|
-
|
-
|
HSBC Sterling Liquidity Fund (Class A)
|
2023
|
Partial
|
1,000
|
1,000
|
1,000
|
-
|
-
|
Total money market
funds
|
|
|
3,000
|
3,000
|
3,000
|
-
|
-
|
Open-ended
investment companies1
|
|
|
|
|
|
|
|
Royal London Short Term Money Market Fund (Class Y
Income)
|
2023
|
Partial
|
986
|
978
|
974
|
(12)
|
(4)
|
Total open-ended
investment companies
|
|
|
986
|
978
|
974
|
(12)
|
(4)
|
|
|
|
|
|
|
|
|
Total
sales
|
|
|
5,779
|
5,668
|
5,692
|
(87)
|
24
|
1 Realisations were completed as part of the treasury management
strategy.
During the year, one private company was
struck off the Register of Companies, resulting in a total realised
loss of £100,000 (cost £100,000). This had no effect on the NAV of
the Company as a full provision had been taken against the value of
the holding in a previous period.
Principal and
Emerging Risks and Uncertainties
The principal and emerging risks and uncertainties
facing the Company were set out in full in the Strategic Report
contained within the 2023 Annual Report, and are the risks
associated with investment in small and medium sized unlisted and
AIM/AQSE quoted companies which, by their nature, carry a higher
level of risk and are subject to lower liquidity than investments
in larger quoted companies. The valuation of investee companies may
be affected by economic conditions, the credit environment and
other risks including legislation, regulation, adherence to VCT
qualifying rules and the effectiveness of the internal controls
operated by the Company and the Manager. These risks and procedures
are reviewed regularly by the Risk Committee and reported to your
Board. The Board continues to monitor the criteria for VCT
qualifying status and can confirm that these are being adhered
to.
Global conflict and political instability was added
to the Risk Register as an emerging risk during a previous period,
as the Directors were not only aware of the heightened cyber
security risk but were mindful of the impact that any change in the
underlying economic conditions could have on the valuation of
investment companies. These included fluctuating interest rates,
increased fuel and energy costs, and the availability of bank
finance, all of which could be impacted during times of
geopolitical uncertainty and volatile markets. The Board and the
Manager continue to monitor the impact of geopolitical issues, and
wider market conditions, on portfolio companies.
Share
Buy-backs
In order to maintain an orderly market in the
Company's shares, the Directors have delegated authority to the
Manager to enable the Company to buy back shares in the secondary
market for cancellation or to be held in treasury, subject always
to such transactions being in the best interests of
Shareholders.
It is intended that the Company will seek to buy
back shares with a view to maintaining a share price that is at a
discount of approximately 5% to the latest published NAV per share,
subject to market conditions, availability liquidity and the
maintenance of the Company's VCT qualifying status. During the
period under review, 5,663,662 shares were bought back at a total
cost of £1.73 million.
Shareholders should note that neither the Company
nor the Manager can execute a transaction in the Company's shares
and an instruction to buy or sell shares on the secondary market
must be directed through a stockbroker. If a Shareholder wishes to
discuss a transaction, they or their broker can contact the
Company's stockbroker, Shore Capital Stockbrokers on 020 7647 8132.
Such transactions are, however, prohibited whilst the Company is in
a closed period, which is the time from the end of a reporting
period until the announcement of the relevant results, or the
release of an unaudited NAV. Additionally, a closed period may be
introduced if the Directors and Manager are in possession of price
sensitive information.
VCT Regulatory
Update
During the period under review, there were no
further amendments to the rules governing VCTs, and your Company
remains fully compliant with the complex conditions and
requirements as set out by HMRC.
Although the precise details of the new government's
economic and fiscal policy are currently unknown, the Manager has,
through the VCT Association (VCTA), been actively involved in
positive cross party dialogue to promote and reinforce the
important role that VCTs play in supporting some of Britain's
brightest and most entrepreneurial smaller companies, whilst also
assisting in job creation across the regions. The announcement in
the 2023 Autumn Statement that the "sunset clause" for VCT and EIS
schemes would be extended until 2035 helps to ensure that VCTs
remain an important component of the UK's funding
infrastructure.
Valuation
Methodology
Consistent with industry best practice, the Board
and the Manager continue to apply the International Private Equity
and Venture Capital Valuation (IPEV) Guidelines as the central
methodology for all private company valuations. The IPEV Guidelines
are the prevailing framework for fair value assessment in the
private equity and venture capital industry. The Directors and the
Manager continue to follow industry guidelines and adhere to the
IPEV Guidelines in all private company valuations. In accordance
with normal market practice, investments quoted on AIM, or another
recognised stock exchange, are valued at their closing bid price at
the period end.
Environmental,
Social and Governance (ESG)
Whilst the Manager continues to enhance its ESG
framework, it should be noted that your Company's investment policy
does not incorporate specific ESG aims, and portfolio companies are
not required to meet any specific targets. However, as a growth
investor, Maven is well positioned to help each company establish
robust ESG practices at an early stage of its corporate
development, ensuring that they are ingrained in the culture as the
business grows. The Manager believes that strong core ESG
credentials helps support responsible growth and encourage positive
social and environmental behaviours.
Your Company has multiple investments in companies
with strong ESG credentials that are achieving growth in expanding
markets. The Manager is committed to maintaining a responsible
approach to new and existing investments and has developed a
framework for promoting ESG credentials by actively engaging with
portfolio companies, taking into consideration material issues at
the point of investment as well as monitoring progress annually.
All potential investment opportunities are required to complete an
ESG assessment, which covers 10 key areas and provides a
comprehensive pre-investment evaluation of the business with a
focus on governance, board composition and culture, alongside
environmental and social considerations.
The Manager continues to be an active signatory to
the UN Principles for Responsible Investment (UNPRI) and Investing
in Women Code. Alongside these external initiatives, Maven has
developed internal diversity initiatives, including launching a
Female Founder Funding programme, which aims to offer mentorship
and collaboration opportunities to female entrepreneurs across the
UK.
Outlook
With a small number of exceptions, the underlying
portfolio of investee companies has delivered a resilient
performance over the past few years and is well positioned to
achieve further growth. Whilst 2023 was a slow year for exits
across the private equity industry, there is clear evidence that
M&A activity is improving. In addition to the three profitable
private company exits completed in the year to date, the companies
within the unlisted portfolio continue to attract regular
acquisition interest from a wide range of credible UK and
international acquirers. The completion of further profitable exits
remains a key objective and will continue to be a focus of
attention in the second half of the year, to help support your
Company's dividend programme.
Graham
Miller
Chair
12 July
2024
Summary of
Investment Changes
For the Six
Months Ended 31 May 2024
|
Valuation
30 November 2023
|
Net
Investment/
(disinvestment)
|
Appreciation/
(depreciation)
|
Valuation
31 May 2024
|
Portfolio
|
£'000
|
%
|
£'000
|
£'000
|
£'000
|
%
|
Unlisted
investments
|
|
|
|
|
|
|
Equities
|
37,095
|
58.5
|
1,007
|
849
|
38,951
|
57.4
|
Loan stocks
|
6,803
|
10.7
|
(822)
|
132
|
6,113
|
9.0
|
|
43,898
|
69.2
|
185
|
981
|
45,064
|
66.4
|
AIM/AQSE
investments1
|
|
|
|
|
|
|
Equities
|
4,544
|
7.1
|
(93)
|
362
|
4,813
|
7.1
|
Listed
investments2
|
|
|
|
|
|
|
OEICs
|
2,027
|
3
|
26
|
(25)
|
2,028
|
3.0
|
MMFs
|
5,500
|
9
|
(500)
|
-
|
5,000
|
7.4
|
Investment trusts
|
3,767
|
5.9
|
656
|
259
|
4,682
|
6.9
|
Total
portfolio
|
59,736
|
94.1
|
274
|
1,577
|
61,587
|
90.8
|
Cash
|
3,492
|
5.5
|
2,364
|
-
|
5,856
|
8.6
|
Other assets
|
332
|
0.4
|
63
|
-
|
395
|
0.6
|
Net assets
|
63,560
|
100.0
|
2,701
|
1,577
|
67,838
|
100.0
|
Ordinary Shares in issue
|
195,399,711
|
|
|
211,399,652
|
|
Net asset value (NAV) per Ordinary Share
|
32.53p
|
|
|
32.09p
|
|
Mid-market price
|
31.60p
|
|
|
30.40p
|
|
Discount to NAV
|
2.89%
|
|
|
5.27%
|
|
|
|
|
|
|
|
|
|
| |
1
Shares traded on the Alternative Investment Market (AIM), the Aquis
Stock Exchange (AQSE) and the Main Market of the London Stock
Exchange.
2
These holdings represent the treasury management portfolio, which
has been constructed from a range of carefully selected, permitted
non-qualifying holdings in investment trusts, open-ended investment
companies (OEICs) and Money Market Funds (MMFs).
Investment
Portfolio Summary
As at 31 May
2024
Investment
|
Valuation
£'000
|
Cost
£'000
|
% of
total assets
|
% of
equity held
|
% of equity
held by
other clients1
|
Unlisted
|
|
|
|
|
|
MirrorWeb Limited
|
3,632
|
1,300
|
5.3
|
8.7
|
41.1
|
Bright Network (UK) Limited
|
2,493
|
1,264
|
3.6
|
7.2
|
31.9
|
Rockar 2016 Limited
(trading as Rockar)
|
1,683
|
1,023
|
2.4
|
4.7
|
14.8
|
2 degrees Limited
(trading as Manufacture 2030)
|
1,385
|
997
|
2.0
|
3.5
|
7.6
|
Horizon Technologies Consultants Limited
|
1,328
|
1,296
|
1.9
|
5.5
|
11.7
|
Horizon Ceremonies Limited
(trading as Horizon Cremation)
|
1,298
|
660
|
1.9
|
3.6
|
49.1
|
Summize Limited
|
1,222
|
647
|
1.8
|
4.1
|
28.3
|
Liftango Group Limited
|
1,195
|
1,195
|
1.8
|
8.2
|
32.5
|
Bud Systems Limited
|
1,057
|
846
|
1.6
|
4.7
|
13.0
|
DiffusionData Limited
|
1,006
|
725
|
1.5
|
3.5
|
14.5
|
Precursive Limited
|
1,000
|
1,000
|
1.5
|
6.8
|
27.7
|
Zinc Digital Business Solutions Limited
|
989
|
677
|
1.5
|
9.0
|
34.7
|
CYSIAM Limited
|
986
|
373
|
1.4
|
6.0
|
21.7
|
CB Technology Group Limited
|
979
|
521
|
1.4
|
10.1
|
64.9
|
NorthRow Limited
|
979
|
979
|
1.4
|
5.0
|
27.8
|
Hublsoft Group Limited
|
969
|
786
|
1.4
|
5.5
|
18.3
|
Nano Interactive Group Limited
|
929
|
625
|
1.4
|
3.7
|
11.2
|
Relative Insight Limited
|
899
|
899
|
1.3
|
5.0
|
26.3
|
Enpal Limited
(trading as Guru Systems)
|
891
|
891
|
1.3
|
7.5
|
14.1
|
mypura.com Group Limited
(trading as Pura)
|
862
|
448
|
1.3
|
2.1
|
20.8
|
Novatus Global Limited
|
861
|
861
|
1.3
|
5.4
|
13.4
|
Draper & Dash Limited
(trading as RwHealth)
|
860
|
860
|
1.3
|
7.7
|
41.2
|
iAM Compliant Limited
|
806
|
489
|
1.2
|
6.3
|
42.8
|
BioAscent Discovery Limited
|
785
|
174
|
1.2
|
4.4
|
35.6
|
Filtered Technologies Limited
|
785
|
750
|
1.2
|
4.1
|
21.3
|
ORCHA Health Limited
|
775
|
775
|
1.1
|
2.7
|
5.1
|
Whiterock Group Limited
|
729
|
520
|
1.1
|
9.3
|
28.6
|
Biorelate Limited
|
718
|
597
|
1.1
|
3.4
|
22.3
|
CODILINK UK Limited
(trading as Coniq)
|
675
|
450
|
1.0
|
1.3
|
3.6
|
Plyable Limited
|
647
|
647
|
1.0
|
7.3
|
19.3
|
Reed Thermoformed Packaging Limited (trading as iPac
Packaging Innovations)
|
631
|
448
|
0.9
|
2.5
|
9.9
|
Turnkey Group (UK) Holdings Limited
|
604
|
1,208
|
0.9
|
15.6
|
23.1
|
QikServe Limited
|
602
|
494
|
0.9
|
2.2
|
13.6
|
Metrion Biosciences Limited
|
597
|
597
|
0.9
|
4.3
|
13.9
|
Sensoteq Limited
|
597
|
597
|
0.9
|
5.6
|
18.0
|
Ensco 969 Limited
(trading as DPP)
|
551
|
435
|
0.8
|
2.2
|
32.3
|
HCS Control Systems Group Limited
|
550
|
373
|
0.8
|
3.0
|
33.5
|
WaterBear Education Limited
|
506
|
245
|
0.7
|
5.0
|
33.8
|
Laverock Therapeutics Limited
|
498
|
498
|
0.7
|
2.3
|
7.0
|
Boomerang Commerce IQ Inc
(trading as CommerceIQ)2
|
484
|
646
|
0.7
|
0.1
|
0.3
|
HiveHR Limited
|
413
|
413
|
0.6
|
6.0
|
38.6
|
Vodat Communications Group (VCG) Holding Limited
|
396
|
264
|
0.6
|
2.3
|
29.6
|
Rico Developments Limited
(trading as Adimo)
|
380
|
760
|
0.6
|
3.4
|
6.5
|
Delio Limited
|
378
|
998
|
0.6
|
3.8
|
14.6
|
Project Falcon Topco Limited
(trading as Quorum Cyber)3
|
377
|
126
|
0.6
|
0.3
|
2.6
|
Flow UK Holdings Limited
|
350
|
498
|
0.5
|
6.0
|
29.0
|
Shortbite Limited
(trading as Fixtuur)
|
327
|
684
|
0.5
|
10.4
|
60.5
|
Servoca PLC4
|
322
|
136
|
0.5
|
1.2
|
-
|
Snappy Shopper Limited
|
307
|
307
|
0.5
|
0.4
|
1.3
|
ebb3 Limited
|
303
|
206
|
0.4
|
6.6
|
72.3
|
XR Games Limited
|
301
|
299
|
0.4
|
1.6
|
21.6
|
RevLifter Limited
|
300
|
300
|
0.4
|
3.1
|
23.5
|
Growth Capital Ventures Limited
|
275
|
264
|
0.4
|
4.8
|
42.6
|
AMufacture Limited
|
261
|
261
|
0.4
|
4.8
|
15.2
|
Alderley Lighthouse Labs Limited
|
249
|
249
|
0.4
|
6.7
|
46.9
|
Cat Tech International Limited
|
243
|
299
|
0.4
|
2.9
|
27.2
|
Automated Analytics Limited
|
220
|
150
|
0.3
|
1.9
|
18.7
|
The Algorithm People Limited
(trading as Optimize)
|
186
|
140
|
0.3
|
2.0
|
14.2
|
Zing TopCo Limited
(trading as Zing)
|
185
|
185
|
0.3
|
4.9
|
42.8
|
McKenzie Intelligence Services Limited
|
159
|
159
|
0.2
|
1.6
|
4.8
|
ISN Solutions Group Limited
|
65
|
250
|
0.1
|
3.6
|
51.4
|
Other unlisted investments
|
24
|
3,296
|
-
|
|
|
Total
unlisted
|
45,064
|
39,060
|
66.4
|
|
|
AIM/AQSE
quoted5
|
|
|
|
|
|
Water Intelligence PLC
|
905
|
163
|
1.4
|
1.2
|
-
|
Concurrent Technologies PLC
|
492
|
161
|
0.8
|
0.6
|
-
|
GENinCode PLC
|
368
|
557
|
0.6
|
4.5
|
17.2
|
Vianet Group PLC
|
355
|
405
|
0.5
|
1.1
|
0.3
|
Avingtrans PLC
|
350
|
54
|
0.5
|
0.3
|
-
|
Pulsar Group PLC
(formerly Access Intelligence PLC)
|
347
|
224
|
0.5
|
0.4
|
0.1
|
Netcall PLC
|
293
|
26
|
0.4
|
0.2
|
-
|
Synectics PLC
|
247
|
308
|
0.4
|
0.8
|
-
|
K3 Business Technology Group PLC
|
195
|
238
|
0.3
|
0.5
|
-
|
Kanabo Group PLC6
|
194
|
1,639
|
0.3
|
2.0
|
7.9
|
Anpario PLC
|
136
|
57
|
0.2
|
0.2
|
-
|
Eden Research PLC
|
133
|
199
|
0.2
|
0.6
|
0.9
|
Arecor Therapeutics PLC
|
115
|
167
|
0.2
|
0.2
|
0.2
|
Croma Security Solutions Group PLC
|
111
|
433
|
0.2
|
1.1
|
-
|
Intelligent Ultrasound Group PLC
|
98
|
118
|
0.1
|
0.4
|
1.5
|
BiVictriX Therapeutics PLC
|
83
|
99
|
0.1
|
0.9
|
-
|
Incanthera PLC
|
70
|
49
|
0.1
|
0.6
|
0.6
|
Transense Technologies PLC
|
44
|
1,188
|
0.1
|
0.3
|
-
|
Merit Group PLC
|
36
|
450
|
0.1
|
0.2
|
-
|
Feedback PLC
|
35
|
74
|
0.1
|
0.4
|
1.3
|
C4X Discovery Holdings PLC
|
28
|
40
|
-
|
0.1
|
0.8
|
Crossword Cybersecurity PLC
|
23
|
150
|
-
|
0.6
|
1.5
|
Avacta Group PLC
|
18
|
7
|
-
|
-
|
0.1
|
Verici Dx PLC
|
17
|
76
|
-
|
0.1
|
1.2
|
Destiny Pharma PLC
|
16
|
69
|
-
|
0.1
|
0.5
|
Directa Plus PLC
|
16
|
120
|
-
|
0.1
|
0.1
|
Gelion PLC
|
15
|
121
|
-
|
0.1
|
0.1
|
XP Factory
PLC
|
15
|
26
|
-
|
-
|
0.1
|
LungLife AI
|
12
|
114
|
-
|
0.3
|
0.2
|
Other quoted investments
|
46
|
4,283
|
-
|
|
|
Total AIM/AQSE
quoted
|
4,813
|
11,615
|
7.1
|
|
|
Private equity
investment trusts7
|
|
|
|
|
|
HgCapital Trust PLC
|
706
|
499
|
1.0
|
-
|
0.1
|
Patria Private Equity Trust PLC
(formerly abrdn Private Equity Opportunities
Trust)
|
486
|
377
|
0.7
|
0.1
|
0.2
|
NB Private Equity Partners Limited
|
400
|
412
|
0.6
|
0.1
|
0.2
|
ICG Enterprise Trust PLC
|
329
|
305
|
0.5
|
-
|
0.2
|
CT Private Equity Trust PLC
|
297
|
300
|
0.4
|
0.1
|
0.3
|
Apax Global Alpha Limited
|
206
|
225
|
0.3
|
-
|
0.1
|
Pantheon International PLC
|
126
|
129
|
0.2
|
-
|
-
|
Caledonia Investments PLC
|
112
|
112
|
0.2
|
-
|
-
|
Total private equity
investment trusts
|
2,662
|
2,359
|
3.9
|
|
|
Global equity
investment trusts7
|
|
|
|
|
|
Alliance Trust PLC
|
181
|
149
|
0.3
|
-
|
-
|
JPMorgan Global Growth & Income PLC
|
175
|
150
|
0.3
|
-
|
-
|
Total global equity
investment trusts
|
356
|
299
|
0.6
|
|
|
Real estate
investment trust7
|
|
|
|
|
|
Impact Healthcare REIT PLC
|
220
|
244
|
0.3
|
0.1
|
0.1
|
Total real estate
investment trust
|
220
|
244
|
0.3
|
|
|
Infrastructure
investment trusts7
|
|
|
|
|
|
BBGI Global Infrastructure SA
|
336
|
372
|
0.5
|
-
|
0.1
|
3i Infrastructure PLC
|
332
|
320
|
0.5
|
-
|
-
|
Pantheon Infrastructure PLC
|
285
|
312
|
0.4
|
0.1
|
0.2
|
International Public Partnerships Limited
|
259
|
300
|
0.4
|
-
|
-
|
JLEN Environmental Assets Group Limited
|
232
|
320
|
0.3
|
-
|
0.1
|
Total infrastructure
investment trusts
|
1,444
|
1,624
|
2.1
|
|
|
Open-ended investment
companies7
|
|
|
|
|
|
Royal London Short Term Fixed Income Fund (Class Y
Income)
|
1,024
|
1,020
|
1.5
|
0.1
|
0.2
|
Royal London Short Term Money Market Fund (Class Y
Income)
|
1,004
|
1,026
|
1.5
|
-
|
-
|
Total open-ended
investment companies
|
2,028
|
2,046
|
3.0
|
|
|
Money market
funds7
|
|
|
|
|
|
Aberdeen Standard Liquidity Fund (Lux) - Sterling Fund
(Class K3)
|
1,000
|
1,000
|
1.5
|
-
|
-
|
Aviva Investors Sterling Government Liquidity Fund
|
1,000
|
1,000
|
1.5
|
-
|
0.1
|
BlackRock Institutional Sterling Government Liquidity
Fund (Core Dis)
|
1,000
|
1,000
|
1.5
|
-
|
0.1
|
Fidelity Institutional Liquidity Sterling Fund (Class
F)
|
1,000
|
1,000
|
1.5
|
0.1
|
0.2
|
HSBC Sterling Liquidity Fund (Class A)
|
1,000
|
1,000
|
1.4
|
-
|
-
|
Total money market
funds
|
5,000
|
5,000
|
7.4
|
|
|
|
|
|
|
|
|
Total
investments
|
61,587
|
62,247
|
90.8
|
|
|
|
|
|
|
|
|
|
| |
1 Other clients of Maven Capital Partners UK LLP.
2 This holding reflects the retained minority interest following
the sale of e.fundamentals (Group) Limited to CommerceIQ in July
2022.
3 Retained minority interest following the sale of Quorum Cyber
Security Limited in December 2021.
4 This company delisted from AIM during a previous
period.
5 Investments are quoted on AIM/AQSE with the exception of
Kanabo Group PLC, which is listed on the Main Market of the London
Stock Exchange.
6 The holding in this investment resulted from the sale of The
GP Service (UK) Limited, which completed in February 2022. The
unlisted shares in Kanabo GP Limited were, in accordance with the
terms of the original transaction, exchanged for shares in Kanabo
Group PLC, which is listed on the Main Market of the London Stock
Exchange.
7 Treasury management portfolio.
Shaded line indicates that the investment was
completed pre November 2015.
Income
Statement
For the Six
Months Ended 31 May 2024
|
Six months ended
31 May 2024 (unaudited)
|
Six months ended
31 May 2023 (unaudited)
|
Year ended
30 November 2023 (audited)
|
|
Revenue
£'000
|
Capital
£'000
|
Total
£'000
|
Revenue
£'000
|
Capital
£'000
|
Total £'000
|
Revenue
£'000
|
Capital
£'000
|
Total
£'000
|
Gain/(loss) on investments
|
-
|
1,577
|
1,577
|
-
|
(958)
|
(958)
|
-
|
(2,419)
|
(2,419)
|
Income from investments
|
481
|
-
|
481
|
234
|
-
|
234
|
736
|
-
|
736
|
Other income
|
83
|
-
|
83
|
132
|
-
|
132
|
187
|
-
|
187
|
Investment management fees
|
(141)
|
(425)
|
(566)
|
(141)
|
(424)
|
(565)
|
(284)
|
(851)
|
(1,135)
|
Other expenses
|
(207)
|
|
(207)
|
(246)
|
-
|
(246)
|
(460)
|
(4)
|
(464)
|
Net return on
ordinary activities before taxation
|
216
|
1,152
|
1,368
|
(21)
|
(1,382)
|
(1,403)
|
179
|
(3,274)
|
(3,095)
|
Tax on ordinary activities
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Return attributable
to Equity Shareholders
|
216
|
1,152
|
1,368
|
(21)
|
(1,382)
|
(1,403)
|
179
|
(3,274)
|
(3,095)
|
Earnings per share
(pence)
|
0.11
|
0.57
|
0.68
|
(0.01)
|
(0.75)
|
(0.76)
|
0.09
|
(1.72)
|
(1.63)
|
|
|
|
|
|
|
|
|
|
| |
All gains and losses are recognised in the
Income Statement.
The total column of this statement is the
Profit & Loss Account of the Company. The revenue and capital
return columns are prepared in accordance with the AIC SORP. All
items in the above statement derive from continuing operations. No
operations were acquired or discontinued during the
period.
There are no potentially dilutive capital
instruments in issue and, therefore, no diluted earnings per share
figures are relevant. The basic and diluted earnings per share are,
therefore, identical.
The accompanying Notes are an integral part of
the Financial Statements.
Statement Of
Changes In Equity
Six Months
Ended 31 May 2024
Six months ended 31
May 2024 (unaudited)
|
Non-distributable
reserves
|
Distributable
reserves
|
|
|
Share
capital
£'000
|
Share premium
account
£'000
|
Capital redemption
reserve
£'000
|
Capital reserve
unrealised
£'000
|
Capital
reserve
realised
£'000
|
Special
distributable
reserve
£'000
|
Revenue
reserve
£'000
|
Total
£'000
|
At
30 November 2023
|
19,539
|
20,068
|
825
|
(874)
|
8,800
|
16,757
|
(1,555)
|
63,560
|
Net return
|
-
|
-
|
-
|
1,764
|
(187)
|
(425)
|
216
|
1,368
|
Dividends paid
|
-
|
-
|
-
|
-
|
-
|
(2,119)
|
(101)
|
(2,220)
|
Repurchase and cancellation of
shares
|
(566)
|
-
|
566
|
-
|
-
|
(1,729)
|
-
|
(1,729)
|
Net proceeds of share
issue
|
2,095
|
4,540
|
-
|
-
|
-
|
-
|
-
|
6,635
|
Net proceeds of DIS issue*
|
71
|
153
|
-
|
-
|
-
|
-
|
-
|
224
|
At
31 May 2024
|
21,139
|
24,761
|
1,391
|
890
|
8,613
|
12,484
|
(1,440)
|
67,838
|
Six months ended 31
May 2023 (unaudited)
|
Non-distributable
reserves
|
Distributable
reserves
|
|
|
Share
capital
£'000
|
Share premium
account
£'000
|
Capital redemption
reserve
£'000
|
Capital
reserve
unrealised
£'000
|
Capital
reserve
realised
£'000
|
Special
distributable
reserve
£'000
|
Revenue
reserve
£'000
|
Total
£'000
|
At
30 November 2022
|
17,638
|
15,063
|
691
|
404
|
9,941
|
20,448
|
(1,734)
|
62,451
|
Net return
|
-
|
-
|
-
|
(1,181)
|
223
|
(424)
|
(21)
|
(1,403)
|
Dividends paid
|
-
|
-
|
-
|
-
|
-
|
(934)
|
-
|
(934)
|
Repurchase and cancellation of
shares
|
(72)
|
-
|
72
|
-
|
-
|
(240)
|
-
|
(240)
|
Net proceeds of share
issue
|
1,714
|
4,321
|
-
|
-
|
-
|
-
|
-
|
6,035
|
Net proceeds of DIS issue*
|
29
|
73
|
-
|
-
|
-
|
-
|
-
|
102
|
At
31 May 2023
|
19,309
|
19,457
|
763
|
(777)
|
10,164
|
18,850
|
(1,755)
|
66,011
|
Year ended 30
November 2023 (audited)
|
Non-distributable
reserves
|
Distributable
reserves
|
|
|
Share
capital
£'000
|
Share premium
account
£'000
|
Capital redemption
reserve
£'000
|
Capital
reserve
unrealised
£'000
|
Capital
reserve
realised
£'000
|
Special
distributable
reserve
£'000
|
Revenue
reserve
£'000
|
Total
£'000
|
At
30 November 2022
|
17,638
|
15,063
|
691
|
404
|
9,941
|
20,448
|
(1,734)
|
62,451
|
Net return
|
-
|
-
|
-
|
(1,278)
|
(1,141)
|
(855)
|
179
|
(3,095)
|
Dividends paid
|
-
|
-
|
-
|
-
|
-
|
(2,400)
|
-
|
(2,400)
|
Repurchase and cancellation of
shares
|
(134)
|
-
|
134
|
-
|
-
|
(436)
|
-
|
(436)
|
Net proceeds of share
issue
|
1,957
|
4,819
|
-
|
-
|
-
|
-
|
-
|
6,776
|
Net proceeds of DIS issue*
|
78
|
186
|
-
|
-
|
-
|
-
|
-
|
264
|
At
30 November 2023
|
19,539
|
20,068
|
825
|
(874)
|
8,800
|
16,757
|
(1,555)
|
63,560
|
*DIS
represents the Dividend Investment Scheme as detailed in the
Interim Review.
The capital reserve unrealised is generally
non-distributable other than the part of the reserve relating to
gains/(losses) attributable to readily realisable quoted
investments which are distributable.
Where all, or an element of the proceeds of
sales have not been received in cash or cash equivalent, and are
not readily convertible to cash, they do not qualify as realised
gains for the purposes of distributable reserves calculations and,
therefore, do not form part of distributable reserves.
The accompanying Notes are an integral part of
the Financial Statements.
Balance
Sheet
As At 31 May
2024
|
31 May 2024
(unaudited)
£'000
|
31 May 2023
(unaudited)
£'000
|
30 November 2023
(audited)
£'000
|
Fixed
assets
|
|
|
|
Investments at fair value through profit or loss
|
61,587
|
58,967
|
59,736
|
Current
assets
|
|
|
|
Debtors
|
699
|
615
|
633
|
Cash
|
5,856
|
6,657
|
3,492
|
|
6,555
|
7,272
|
4,125
|
Creditors
|
|
|
|
Amounts falling due within one year
|
(304)
|
(228)
|
(301)
|
Net current
assets
|
6,251
|
7,044
|
3,824
|
Net assets
|
67,838
|
66,011
|
63,560
|
Capital and
reserves
|
|
|
|
Called up share capital
|
21,139
|
19,309
|
19,539
|
Share premium account
|
24,761
|
19,457
|
20,068
|
Capital redemption reserve
|
1,391
|
763
|
825
|
Capital reserve - unrealised
|
890
|
(777)
|
(874)
|
Capital reserve - realised
|
8,613
|
10,164
|
8,800
|
Special distributable reserve
|
12,484
|
18,850
|
16,757
|
Revenue reserve
|
(1,440)
|
(1,755)
|
(1,555)
|
Net assets
attributable to Ordinary Shareholders
|
67,838
|
66,011
|
63,560
|
Net asset value per
Ordinary Share (pence)
|
32.09
|
34.18
|
32.53
|
The Financial Statements of Maven Income and
Growth VCT 5 PLC, registered number 04084875, were approved and
authorised for issue by the Board of Directors and were signed on
its behalf by:
Graham
Miller
Director
12 July
2024
The accompanying Notes are an integral part of
the Financial Statements.
Cash Flow
Statement
For the Six
Months Ended 31 May 2024
|
Six months ended 31 May 2024
(unaudited)
£'000
|
Six months ended 31 May 2023
(unaudited)
£'000
|
Year ended
30 November 2023
(audited)
£'000
|
Net cash flows from
operating activities
|
(271)
|
(822)
|
(1,136)
|
Cash flows from
investing activities
|
|
|
|
Purchase of investments
|
(5,967)
|
(17,446)
|
(24,207)
|
Sale of investments
|
5,692
|
659
|
5,220
|
Net cash flows from
investing activities
|
(275)
|
(16,787)
|
(18,987)
|
Cash flows from
financing activities
|
|
|
|
Equity dividends paid
|
(2,220)
|
(934)
|
(2,400)
|
Issue of Ordinary Shares
|
6,859
|
6,137
|
7,148
|
Repurchase of Ordinary Shares
|
(1,729)
|
(240)
|
(436)
|
Net cash flows from
financing activities
|
2,910
|
4,963
|
4,312
|
|
|
|
|
Net
increase/(decrease) in cash
|
2,364
|
(12,646)
|
(15,811)
|
Cash at beginning of
period
|
3,492
|
19,303
|
19,303
|
Cash at end of
period
|
5,856
|
6,657
|
3,492
|
The accompanying Notes are an integral part of
the Financial Statements.
Notes to the
Financial Statements
1.
Accounting policies
The financial information for the six months ended
31 May 2024 and the six months ended 31 May 2023 comprises
non-statutory accounts within the meaning of s435 of the Companies
Act 2006. The financial information contained in this report has
been prepared on the basis of the accounting policies set out in
the Annual Report and Financial Statements for the year ended 30
November 2023, which have been filed at Companies House and
contained an Auditor's Report that was not qualified and did not
contain a statement under s498 (2) or s498 (3) of the Companies Act
2006.
2.
Reserves
Share premium
account
The share premium account represents the premium
above nominal value received by the Company on issuing shares net
of issue costs, including £61,395 current period (£169,359
cumulative) trail commission. This reserve is
non-distributable.
Capital redemption
reserve
The nominal value of shares repurchased and
cancelled is represented in the capital redemption reserve. This
reserve is non-distributable.
Capital reserve -
unrealised
Increases and decreases in the fair value of
investments are recognised in the Income Statement and are then
transferred to the capital reserve unrealised account. This reserve
is generally non-distributable other than the part of the reserve
relating to gains/(losses) attributable to readily realisable
quoted investments which are distributable.
Capital reserve -
realised
Gains or losses on investments realised in the
period that have been recognised in the Income Statement are
transferred to the capital reserve realised account on disposal.
Furthermore, any prior unrealised gains or losses on such
investments are transferred from the capital reserve unrealised
account to the capital reserve realised account on disposal. This
reserve is distributable.
Special
distributable reserve
The total cost to the Company of the repurchase and
cancellation of shares is represented in the special distributable
reserve account. The special distributable reserve also represents
capital dividends, capital investment management fees and the tax
effect of capital items. This reserve is distributable.
Revenue
reserve
The revenue reserve represents accumulated profits
retained by the Company that have not been distributed to
Shareholders as a dividend. This reserve is distributable.
3.
Return per Ordinary
Share
|
Six months ended 31 May 2024
|
The returns per share have been based on the following
figures:
Weighted average number of Ordinary Shares
Revenue return
Capital return
|
202,443,505
£216,000
£1,152,000
|
Total
return
|
£1,368,000
|
Directors'
Responsibility Statement
The Directors confirm that, to the best of
their knowledge:
• the Financial Statements
for the six months ended 31 May 2024 have been prepared in
accordance with FRS 102, the Financial Reporting Standard
applicable in the UK and Republic of Ireland;
• the Interim Management
Report includes a fair review of the information required by DTR
4.2.7R in relation to the indication of important events during the
first six months, and of the principal and emerging risks and
uncertainties facing the Company during the second six months, of
the year ending 30 November 2024; and
• the Interim Management
Report includes adequate disclosure of the information required by
DTR 4.2.8R in relation to related party transactions and any
changes therein.
Other
information
The NAV per Ordinary Share has been calculated
using the number of Ordinary Shares in issue at 31 May 2024, which
was 211,399,652. A summary of investment changes for the six months
under review and an investment portfolio summary as at 31 May 2024
are included above. A full copy of the Interim Report and Financial
Statements will be printed and issued to Shareholders in due
course. Copies of this announcement will be available to the public
at the office of Maven Capital Partners UK LLP, Kintyre House, 205
West George Street, Glasgow, G2 2LW; at the registered office of
the Company at 6th Floor, Saddlers House, 44 Gutter Lane, London
EC2V 6BR; and on the Company's website at: mavencp.com/migvct5.
Neither the content of the Company's website
nor the contents of any website accessible from hyperlinks on the
Company's website (or any other website) is incorporated into, or
forms part of, this announcement.
By order of the
Board
Maven Capital
Partners UK LLP
Secretary
12 July
2024